Archives
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2018-07
-
1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine in Src Kinase P
2026-07-29
PP 3 empowers researchers to distinguish true Src kinase inhibition from off-target effects, ensuring data specificity in complex cell signaling studies. Its validated use as a negative control for PP 2 streamlines workflows and troubleshooting in protein tyrosine kinase research. Choose APExBIO for high-purity, research use only chemical reagents.
-
TH287 Radiosensitizes CRPC Cells by Targeting MTH1-Mediated
2026-07-29
This study demonstrates that the MTH1 inhibitor TH287 significantly enhances the sensitivity of castration-resistant prostate cancer (CRPC) cells to ionizing radiation by promoting apoptosis and cell cycle arrest. The findings point to optimized timing for combination therapy and underscore the translational potential of MTH1 inhibition in radiosensitization strategies for resistant prostate cancers.
-
Collagen VI-Enriched ECM Scaffolds Enhance iPSC Islet Organo
2026-07-28
Zhu et al. demonstrate that decellularized amniotic membrane (dAM) scaffolds enriched with collagen VI significantly improve the viability, functional maturity, and engraftment of iPSC-derived islet organoids. These findings advance biomimetic strategies for diabetes cell therapy and highlight the critical role of extracellular matrix composition in organoid engineering.
-
Technical Application of Anti-HMGB1 Rabbit Monoclonal Antibo
2026-07-28
The Anti-HMGB1 Rabbit Monoclonal Antibody (SKU MA3057) enables specific detection of HMGB1 protein in human, mouse, and rat samples, supporting workflows such as Western blot, immunohistochemistry, and flow cytometry. This reagent is intended strictly for research use and is not validated for diagnostic or therapeutic applications.
-
AL-8810: Selective Prostaglandin F2α Antagonist for FP Studi
2026-07-27
AL-8810 is a highly selective prostaglandin F2α antagonist. It enables precise inhibition of FP receptor-mediated signaling in vascular and endometrial models. Its nanomolar potency and DMSO solubility make it a reference compound in research on PGF2α pathways.
-
Oltipraz: Precision Nrf2 Activation for MASLD & Detoxificati
2026-07-27
Oltipraz (4-methyl-5-(pyrazin-2-yl)-3H-1,2-dithiole-3-thione) enables reproducible activation of the Nrf2 pathway and phase II enzyme induction, making it a cornerstone for chemoprevention and MASLD research. This article details evidence-backed workflows, key innovations in autophagy and ferroptosis modulation, and troubleshooting guidance to maximize assay reliability.
-
Methoxy-X04: Advanced Fluorescent Amyloid Beta Probe in AD M
2026-07-26
Methoxy-X04 stands out as a brain-permeable fluorescent amyloid beta probe, empowering researchers with high-contrast in vivo imaging of amyloid pathology. Its robust affinity for Aβ aggregates streamlines Alzheimer’s disease research workflows and enables real-time visualization of plaque clearance, bridging preclinical discovery with translational impact.
-
Mitoxantrone HCl: A Dual-Mechanism Tool for Resistance-Busti
2026-07-25
Explore how Mitoxantrone HCl, a potent DNA topoisomerase II inhibitor, is fueling a paradigm shift in translational cancer research. From classic DNA damage to novel allosteric targeting of estrogen receptor alpha, this article synthesizes mechanistic insight, experimental validation, and actionable strategy—guiding researchers to leverage Mitoxantrone HCl for overcoming endocrine resistance and driving discovery across oncology and stem cell workflows.
-
Sodium Nitroprusside: Advanced Strategies for Sex-Specific V
2026-07-24
Discover how Sodium Nitroprusside, a potent nitric oxide donor, enables nuanced exploration of sex-specific vascular mechanisms. This article uniquely bridges molecular action with practical assay strategies for dissecting hypertension development.
-
Streptavidin-HyperFluor 647: Decoding Biotin Detection Limit
2026-07-24
Explore how Streptavidin-HyperFluor 647, a leading Streptavidin fluorescent conjugate, redefines the sensitivity and specificity of biotinylated molecule detection. This article uniquely dissects molecular mechanisms and recent assay innovations, empowering advanced fluorescence microscopy and proteomics workflows.
-
Methotrexate: Folate Antagonist Mechanisms & Research Protoc
2026-07-23
Methotrexate is a folate antagonist that potently inhibits dihydrofolate reductase, modulating DNA synthesis and immunological pathways. Its use as an anti-inflammatory and apoptosis-inducing agent is well established in both cell-based and animal model research. This dossier details its molecular mechanism, protocols, and critical application boundaries.
-
Sugar Moiety in Protopanaxadiol Ginsenosides Modulates GR-Dr
2026-07-23
This study reveals that the number and type of sugar moieties attached to protopanaxadiol ginsenosides critically influence their ability to bind and modulate the glucocorticoid receptor (GR) and thereby regulate lipid metabolism. The findings provide a structural basis for optimizing ginsenoside derivatives as potential hypolipidemic agents with unique regulatory profiles distinct from traditional glucocorticoids.
-
IL-34-Driven Macrophage Reprogramming in p53-Inactivated Tum
2026-07-22
This study uncovers how p53 inactivation leads to immune evasion by triggering IL-34 secretion from cancer stem cells, which drives tumor-associated macrophages toward an immunosuppressive phenotype. The findings elucidate a novel axis of tumor immune escape and highlight therapeutic opportunities for targeting the IL-34-CD36 pathway in p53-mutant cancers.
-
D-Lin-MC3-DMA: Precision Ionizable Lipid for mRNA & siRNA De
2026-07-22
Explore how D-Lin-MC3-DMA, a leading ionizable cationic liposome, transforms mRNA and siRNA delivery. This article uniquely examines the synergy between empirical performance and machine learning-driven formulation, offering actionable insights for next-generation nucleic acid therapeutics.
-
HHV-7 DNA Co-detection in Ocular Toxoplasmosis: Diagnostic I
2026-07-21
This case study is the first to report concurrent detection of Toxoplasma gondii and human herpesvirus 7 (HHV-7) DNA in the vitreous humor of a patient with infectious uveitis. The findings highlight the complexity of chronic ocular infections and suggest a possible role for HHV-7 reactivation in persistent or refractory ocular toxoplasmosis.